A recent paper by Gillian Duchesne et al. was mentioned by Akhil Santhosh, Medical Oncologist at AIIMS Delhi, on X:
“Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
For rising psa post local therapy, immediate ADT has OS benefit.”
Authors: Gillian Duchesne, Henry Woo, Julie Bassett, Keen Hun Tai, Sandra Turner et al.
More posts featuring Akhil Santhosh.